Pramlintide improved glycemic control without increased risk of hypoglycemia in patients with type 2 diabetes using basal insulin

被引：0
|
作者：
Lutz, Karen
Maier, Holly
Zhang, Bei
Frias, Juan
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A143 / A143
页数：1
相关论文
共 50 条
  • [31] In type 1 diabetes, addition of pramlintide to insulin therapy resulted in long-term glycemic improvement without the increase in severe hypoglycemia noted in patients treated with insulin alone
    Maggs, DG
    Fineman, MS
    Burrell, TA
    Gottleib, AB
    Kolterman, OG
    [J]. DIABETES, 2001, 50 : A442 - A442
  • [32] Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets
    Kolterman, O
    Maggs, D
    Fineman, M
    Burrell, T
    Strobel, S
    Shen, L
    Weyer, C
    [J]. DIABETOLOGIA, 2002, 45 : A240 - A240
  • [33] Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets
    Ratner, R
    Whitehouse, F
    Fineman, MS
    Strobel, S
    Shen, L
    Maggs, DG
    Kolterman, OG
    Weyer, C
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (04) : 199 - 204
  • [34] EVALUATION OF GLYCEMIC CONTROL USING AN ALGORITHM FOR BASAL BOLUS INSULIN THERAPY IN HOSPITALISED PATIENTS WITH DIABETES MELLITUS TYPE 2
    Mader, J. K.
    Neubauer, K. M.
    Schaupp, L.
    Aberer, F.
    Augustin, T.
    Spat, S.
    Hoell, B.
    Beck, P.
    Plank, J.
    Pieber, T. R.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A8 - A8
  • [35] Linagliptin Improved Glycemic Control Without Weight Gain or Hypoglycemia in Patients With Type 2 Diabetes Inadequately Controlled by a Combination of Metformin and Pioglitazone
    Bajaj, Mandeep
    Gilman, Ronald
    Patel, Sanjay
    Kempthorne-Rawson, Joan
    Woerle, Hans-Juergen
    [J]. DIABETES, 2013, 62 : A283 - A283
  • [36] Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes
    Pullman, John
    Darsow, Tamara
    Frias, Juan P.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (03) : 203 - 212
  • [37] Insulin Pump Therapy in Patients with Type 2 Diabetes Safely Improved Glycemic Control Using a Simple Insulin Dosing Regimen
    Edelman, Steven V.
    Bode, Bruce W.
    Bailey, Timothy S.
    Kipnes, Mark S.
    Brunelle, Rocco
    Chen, Xiaojing
    Frias, Juan P.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (08) : 627 - 633
  • [38] ETANERCEPT-INDUCED HYPOGLYCEMIA AND IMPROVED GLYCEMIC CONTROL IN A PATIENT WITH TYPE 2 DIABETES
    Farrokhi, Farnoosh
    Taylor, Harris C.
    McBride, Nancy M.
    [J]. ENDOCRINE PRACTICE, 2011, 17 (02) : 306 - 307
  • [39] The influence of improved glycemic control on hypoglycemia counter-regulation in type 2 diabetes
    Brehm, A.
    [J]. DIABETOLOGE, 2009, 5 (03): : 214 - 215
  • [40] Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin Reply
    Martens, Thomas W.
    Beck, Roy W.
    Bergenstal, Richard M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (13): : 1330 - +
12345